Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives

Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives

Wilma Barcellini, Bruno Fattizzo, Anna ZaninoniUOC Ematologia, Fondazione IRCCS Ca’ Grande Ospedale Maggiore Policlinico, Milano, ItalyAbstract: Autoimmune hemolytic anemia (AIHA) is increasingly observed after allogeneic hematopoietic stem cell transplantation (allo-HSCT), with a reported...

Full description

Bibliographic Details
Main Authors: Barcellini W, Fattizzo B, Zaninoni A
Format: Article
Language:English
Published: Dove Medical Press 2019-08-01
Series:Journal of Blood Medicine
Subjects:
Autoimmune hemolytic anemia
allogeneic hematopoietic stem cell transplantation
rituximab
sirolimus and abatacept
bortezomib and daratumumab
Online Access:https://www.dovepress.com/management-of-refractory-autoimmune-hemolytic-anemia-after-allogeneic--peer-reviewed-article-JBM

Internet

https://www.dovepress.com/management-of-refractory-autoimmune-hemolytic-anemia-after-allogeneic--peer-reviewed-article-JBM

Similar Items